GenesisCare Repairing COVID Disrupted Pathways in Breast Cancer Care with First Sunnyvale Women’s Center

Sunnyvale, Texas, the only facility dedicated to multidisciplinary breast healthcare, utilizes advanced diagnostics to deliver personalized care and the best possible life outcomes

SUNNYVALE, Texas--(BUSINESS WIRE)-- GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom—today announced the opening of its new Sunnyvale Women’s Center with patient-friendly facilities and an experienced clinical team to this new site to provide Dallas-area residents with end-to-end, multidisciplinary breast healthcare. The comprehensive patient-centered services available include mammography, diagnosis, treatment, and post-treatment follow-up. Patients will have rapid access to advanced and innovative technologies that deliver unprecedented accuracy, faster treatment sessions, and a reduced risk of side effects.

On average, one-in-eight American women (13%)¹ will develop breast cancer in their lifetime. In 2022, we will see approximately 287,850² new cases of invasive breast cancer, along with 51,400 new non-invasive (in situ) breast cancer. The American Cancer Society ranked Texas as the second state in the nation for having the highest number of cases per capita, with an estimated 20,900 new cases of female breast cancer with 3,420 deaths in 2021.

“The Sunnyvale Women’s Center allows us to meet the need for effective, targeted diagnosis and treatment with easy, local access,” shares Dr. Anita Tharian, DO, GenesisCare Medical Oncologist. “Bridging gaps in care is especially important as regular women’s screening and care being disrupted by COVID across the Dallas area.”

Two-time cancer survivor and GenesisCare patient Brenda George shares, “My experiences with GenesisCare have been truly phenomenal. I began receiving treatment immediately after being diagnosed, which helped me improve my chances of fighting my cancer. My oncologist, Dr. Tharian, made my recovery her top priority.”

Dr. Tharian adds, “Offering access to advanced precision medicine, like DCISionRT, has proven to help patients and doctors make informed decisions about their care. Combined with other leading technologies like AlignRT, we are also able to lower the risk of heart damage in radiation treatment for breast cancer.”

The women’s center’s world-leading diagnostic tools and treatments use various advanced technologies to streamline the process and deliver patients’ best possible life outcomes. Innovative tools include:

• AlignRT®—a surface-guided radiation therapy—provides unprecedented accuracy and efficiency using 3-D cameras, so it pauses at the slightest movement.

• DCISionRT® -delivers the most advanced Ductal Carcinoma in Situ (DCIS) test available by looking at the biology of an individual’s specific cancer using a molecular assessment to predict risk and guide treatment plans for better outcomes.

• Hologic®'s 3D mammography -new 3Dimensions™system provides a more comfortable mammography experience and higher-quality 3D images for radiologists to find invasive cancers regardless of age or breast density.

• Hologic®'s DXA system—the latest in densitometry technology—measures bone density and has a complete fracture risk assessment.

For more information on GenesisCare, visit genesiscare.com/us (formerly 21^st Century Oncology). To view the complete list of precautions GenesisCare U.S. centers are taking to ensure patient and staff safety, visit https://www.genesiscare.com/us/covid-19/.

References

1. https://www.breastcancer.org/symptoms/understand_bc/statistics
2. www.BreastCancer.org

About GenesisCare

GenesisCare is an Australian headquartered private company and is one of the world’s largest cancer treatment providers. The organization has already committed more than $300 million to upgrade technology and cancer treatment services across the United States. Every year GenesisCare clinical teams see more than 400,000 people at more than 440 locations. This includes our 293 locations in the U.S., 38 locations in Australia, 14 in the U.K., and 21 in Spain. Globally, the organization employs more than 5,500 highly trained physicians, healthcare professionals, and support staff across Australia, the UK, Spain, and now in the U.S.

GenesisCare is heavily focused on clinical research and innovation in healthcare and leads or is a part of more than 150 clinical trials worldwide.

Our purpose is to design care experiences that get the best possible life outcomes. We believe that care should be focused on the individual, not the condition, and are proud of our world-class patient satisfaction ratings. For more information, visit genesiscare.com. Follow us on Facebook here and LinkedIn here, #designingbettercare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220120005331/en/